Reduction in bleomycin-induced lung hydroxyproline content by an iron chelating agent.
J I
JI
Kennedy
D B
DB
Chandler
R M
RM
Jackson
J D
JD
Fulmer
D000818:Animals; D001761:Bleomycin / Q000633:toxicity*; D002614:Chelating Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006224:Cricetinae; D003676:Deferoxamine / Q000494:pharmacology / Q000627:therapeutic use*; D006909:Hydroxyproline / Q000032:analysis*; D007501:Iron / Q000502:physiology*; D008168:Lung / Q000032:analysis / Q000187:drug effects*; D008297:Male; D008647:Mesocricetus; D010100:Oxygen / Q000378:metabolism; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000517:prevention & control*; D051381:Rats
D002614:Chelating Agents; D001761:Bleomycin; D007501:Iron; D003676:Deferoxamine; D006909:Hydroxyproline; D010100:Oxygen